AH-3365

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs

This week, Phispers tells us why David Hung’s taking charge as CEO of Axovant could signal the

Singh bros hit back at Daiichi in Ranbaxy case; New drug shortages legislation in Canada

This week, Phispers brings you the latest twist in the Singh brothers-Daiichi 2008 Ranbaxy sell-off

Plan an African safari to discover the world’s fastest growing pharmaceutical opportunity

Africa represents the last geographic frontier where high growth is still achievable. Over the past